Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IGNX001
Clinical trial NCT06331728 · COMPLETED
Trial details
- NCT number
- NCT06331728
- Sponsor
- IgGenix Australia Pty Ltd
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-01
- Primary completion
- 2025-11-06
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.